重组旋毛虫半胱氨酸蛋白酶抑制剂在脓毒症急性肝损伤治疗中的研究OA
Study on recombinant trichinella spiralis cystatin protease inhibitor in the treatment of acute liver injury in sepsis
目的:探讨重组旋毛虫半胱氨酸蛋白酶抑制剂(recombinant trichinella spiralis cystatin protease inhibitor,r TS-Cys)在脓毒症急性肝损伤治疗中的潜在作用.方法:雄性 C57BL/6小鼠随机分为 7组(n=10)[Sham组、CLP组、CLP+r TS-Cys组(包括10、20、30、40 μg 4组)、CLP+DEX组].CLP和CLP+r TS-Cys组采取盲肠结扎穿孔法建立小鼠脓毒症急性肝损伤小鼠模型,Sham组行开腹后不做其他处理,立即缝合关腹.术后1 h,CLP组腹腔注射100 μL PBS,CLP+r TS-Cys组腹腔注射含不同剂量r TS-Cys的100 μL PBS,CLP+DEX 组使用等量的地塞米松药物.24 h后,处死小鼠,通过 H&E 染色评价肝脏病理变化;ELISA 法检测血清中 TNF-α、IL-6、IL-10、TGF-β的表达水平;于全自动生化分析仪检测血清中 ALT 和AST水平;采用 Western blot法检测 NF-κB/MAPK信号通路蛋白的表达情况.结果:生存分析提示 r TS-Cys能提高脓毒症小鼠的存活率,20 μg组小鼠术后 72 h存活率最高,进入后续实验.H&E染色结果显示CLP组肝组织结构紊乱和炎症细胞浸润,CLP+r TS-Cys和CLP+DEX组小鼠肝组织较CLP组病理损伤减轻,炎症细胞浸润明显减少;ELISA结果显示小鼠血清TNF-α、IL-6水平比较:CLP组较Sham组明显升高,CLP+r TS-Cys和CLP+DEX组较CLP组降低;IL-10、TGF-β水平比较:CLP组较Sham组升高,CLP+r TS-Cys 和 CLP+DEX 组较 CLP 组升高;肝功能分析 ALT 和 AST 结果显示 CLP 组较 Sham 组明显升高,CLP+r TS-Cys和CLP+DEX组较CLP组降低.Western blot结果显示CLP组NF-κB/MAPK信号通路蛋白表达量上调,CLP+r TS-Cys组的该通路表达较CLP组下调.结论:r TS-Cys可通过下调NF-κB/MAPK信号通路抑制促炎细胞因子的表达,并促进调节性细胞因子的表达,进而保护脓毒症诱发的急性肝损伤.
Objective:To investigate the potential role of recombinant trichinella spiralis cystatin protease inhibitor(r TS-Cys)in the treatment of acute liver injury in sepsis.Methods:Male C57BL/6 mice were randomly divided into 7 groups(n=10)[Sham group,CLP group,CLP+r TS-Cys group(including 10,20,30,40 μg),CLP+DEX group].The CLP and CLP+r TS-Cys groups were used to establish a mouse model of sepsis-induced acute liver injury by cecal ligation and puncture.The Sham group underwent laparotomy without other treatment,and the abdomen was closed immediately.One hour later,100 μL PBS was intraperitoneally injected in the CLP group mice,and 100 μL PBS containing different doses r TS-Cys was intraperitone-ally injected in the CLP+r TS-Cys groups mice,and the same amount of dexamethasone was used in the CLP+DEX group.After 24 hours,the mice were sacrificed and the pathological changes of the liver were evaluated by H&E staining.The expression lev-els of TNF-α,IL-6,IL-10 and TGF-β in serum were detected by ELISA.The levels of ALT and AST in serum were detected by automatic biochemical analyzer.The expression of NF-κB/MAPK signaling pathway proteins was detected by Western blot.Results:Survival analysis suggested that r TS-Cys could improve the survival rate of septic mice,The 20 μg group of mice exhibit-ed the highest survival rate at 72 h post-operation and proceeded to the subsequent experiments.H&E staining results showed that the liver tissue structure of the CLP group was disordered and inflammatory cell infiltration was observed.Compared to the CLP group,the pathological damage of the liver tissue in the CLP+r TS-Cys group and CLP+DEX group was alleviated,and the in-flammatory cell infiltration was significantly reduced.ELISA analysis demonstrated distinct patterns in inflammatory markers.Se-rum TNF-α and IL-6 levels were significantly elevated in the CLP group compared to the Sham group,with subsequent reduction observed in the CLP+r TS-Cys group and CLP+DEX group.Conversely,anti-inflammatory cytokines IL-10 and TGF-β showed progressive increases across groups,with CLP levels exceeding Sham values,and CLP+r TS-Cys group and CLP+DEX group exhibiting the highest levels.Liver function parameters,including ALT and AST,were markedly elevated in the CLP group com-pared to Sham controls,while treatment with r TS-Cys and DEX effectively lowered these enzyme levels below those observed in the CLP group.Western blot results showed that the expression of NF-κB/MAPK signaling pathway protein was up-regulated in the CLP group,and the expression of this pathway in the CLP+r TS-Cys group was lower than that in the CLP group.Conclu-sion:rTS-Cys can inhibit the expression of pro-inflammatory cytokines and promote the expression of regulatory cytokines by down-regulating the NF-κB/MAPK signaling pathway,thereby protecting sepsis-induced acute liver injury.
杨立春;周情毅;蒲传航;严华悦;王胜威;汪雨姝;成浩源;胡小冬;褚亮
蚌埠医科大学第二附属医院,安徽 蚌埠 233000||安徽省感染与免疫重点实验室,安徽 蚌埠 233000蚌埠医科大学第二附属医院,安徽 蚌埠 233000蚌埠医科大学第二附属医院,安徽 蚌埠 233000蚌埠医科大学第二附属医院,安徽 蚌埠 233000蚌埠医科大学第二附属医院,安徽 蚌埠 233000蚌埠医科大学临床医学院,安徽 蚌埠 233000蚌埠医科大学临床医学院,安徽 蚌埠 233000蚌埠医科大学组织学与胚胎学教研室,安徽 蚌埠 233000蚌埠医科大学第二附属医院,安徽 蚌埠 233000
医药卫生
重组旋毛虫半胱氨酸蛋白酶抑制剂脓毒症肝损伤抗炎
Recombinant trichinella spiralis cystatin protease inhibitorSepsisLiver injuryAnti-inflammatory
《海南医科大学学报》 2026 (13)
986-993,8
This study was supported by the Department Level Key Laboratory Open Project(AHIAI2022K02)Bengbu Medical College 2023 Graduate Research and Innovation Program(Byycx23126). 厅级重点实验室开放课题(AHIAI2022K02)蚌埠医学院2023年度研究生科研创新计划项目(Byycx23126)
评论